This inventor holds 1 USPTO granted patent. Top assignee: National Dong Hwa University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Fu-Wen Kuo: Innovator in Cancer Treatment
Introduction
Fu-Wen Kuo is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work focuses on the extraction and application of specific compounds that have the potential to inhibit cancer cell growth.
Latest Patents
Fu-Wen Kuo holds a patent for a groundbreaking invention titled "Scalarane sesterterpenoid, pharmaceutical composition and topoisomerase II and Hsp90 inhibitor for treating cancer, and use and preparation method thereof." This patent discloses scalarane sesterterpenoids represented by formula (I) and meroditerpenoid represented by formula (II), which are extracted from specific sponge species. The compounds of formula (I) are designed to act as anticancer agents, targeting topoisomerase II and Hsp90, thereby providing a pharmaceutical composition for cancer treatment. He has 1 patent to his name.
Career Highlights
Fu-Wen Kuo is affiliated with National Dong Hwa University, where he continues to engage in research and development in the field of pharmaceuticals. His academic background and research endeavors have positioned him as a key figure in the fight against cancer.
Collaborations
Throughout his career, Fu-Wen Kuo has collaborated with esteemed colleagues, including Kuei-Hung Lai and Ying-Chi Du. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Fu-Wen Kuo's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work exemplifies the potential of natural compounds in developing effective therapies for cancer.